Literature DB >> 7228593

Carcino-embryonic antigen assay as a guide to tumour bulk, response to therapy and prognosis in human breast cancer.

B Cantwell, M J Duffy, J J Fennelly, M Jones, G Duffy, L Daly.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7228593     DOI： 10.1007/bf02939191

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  7 in total

1.  Relationship between plasma carcinoembryonic antigen and prognosis in women with breast cancer.

Authors:  D Y Wang; R A Bulbrook; J L Hayward; J C Hendrick; P Franchimont
Journal:  Eur J Cancer       Date:  1975-09       Impact factor: 9.162

2.  Biological markers in breast carcinoma. III. Clinical correlations with carcinoembryonic antigen.

Authors:  D C Tormey; T P Waalkes; J J Snyder; R M Simon
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

3.  Carcinoembryonic antigen in breast cancer patients: serum levels and disease progress.

Authors:  A M Steward; D Nixon; N Zamcheck; A Aisenberg
Journal:  Cancer       Date:  1974-05       Impact factor: 6.860

4.  Evaluation of carcinoembryonic antigen in human mammary carcinoma.

Authors:  T M Chu; T Nemoto
Journal:  J Natl Cancer Inst       Date:  1973-10       Impact factor: 13.506

5.  Assessment of biochemical tests to screen for metastases in patients with breast cancer.

Authors:  R C Coombes; T J Powles; J C Gazet; A G Nash; H T Ford; A McKinna; A M Neville
Journal:  Lancet       Date:  1980-02-09       Impact factor: 79.321

6.  Carcinoembryonic antigen in breast-cancer tissue: a useful prognostic indicator.

Authors:  S Shousha; T Lyssiotis; V M Godfrey; P J Scheuer
Journal:  Br Med J       Date:  1979-03-24

7.  Tumour markers in breast cancer.

Authors:  D H Cove; K L Woods; S C Smith; D Burnett; J Leonard; R J Grieve; A Howell
Journal:  Br J Cancer       Date:  1979-11       Impact factor: 7.640
  7 in total
  4 in total

1.  The clinical value of tissue carcinoembryonic antigen in breast cancer.

Authors:  S Haga; O Watanabe; T Shimizu; H Imamura; T Iida; M Makita; T Kajiwara
Journal:  Jpn J Surg       Date:  1991-05

2.  Evaluation of follow-up methods to detect relapse after mastectomy in breast cancer patients.

Authors:  B Cantwell; J J Fennelly; M Jones
Journal:  Ir J Med Sci       Date:  1982-01       Impact factor: 1.568

3.  Prospective assessment of the role of five tumour markers in breast cancer.

Authors:  J F Robertson; D Pearson; M R Price; C Selby; J Pearson; R W Blamey; A Howell
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

Review 4.  Circulating tumour markers in breast cancer.

Authors:  Ettore Seregni; Antonio Coli; Nicola Mazzucca
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-04       Impact factor: 9.236
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.